Human Insulin (rDNA) from Japan
Recombinant human insulin produced via DNA technology, a polypeptide hormone used primarily for treating diabetes mellitus. Classified under HTS 2937.12.00.00 as a synthetic reproduction of insulin, the exact structural analogue of natural human insulin. Meets chapter 29 requirements for chemically defined organic compounds used as hormones.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Requires FDA approval and biologics license; provide certificates of analysis confirming rDNA origin and purity
• Maintain strict cold chain (2-8°C) documentation throughout transport to preserve bioactivity
• Declare as 'insulin, synthetic' to avoid misclassification with pharmaceutical preparations in Chapter 30